DN

dNovo

YC S18

San Francisco, US · Founded 2018 · 4 employees · Inactive · 1 known investors

dnovobio.com ↗

dNovo develops direct reprogramming technology to convert skin, blood, or fat cells into new stem cells, targeting age-related stem cell depletion. The company aims to address aging through cellular regeneration for consumers.

Founders & leadership· Y Combinator alumni (S18)

Ernesto LujaninFounder

Investors · 1

Y

Y CombinatorMountain View · $500K – $500K